<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="2-part\PMC6783926\results\search\disease\results.xml">
  <result pre="phenotypic versus target-based screening strategy was established to identify the" exact="influenza" post="A virus inhibitors targeting the virus RNA transcription/replication steps"/>
  <result pre="indicates that the primary screen was robust for identification of" exact="influenza" post="A virus inhibitors targeting RdRp activity. Finally, two hit"/>
  <result pre="inhibitor 1. Introduction Influenza is an acute respiratory and highly" exact="infectious disease" post="that is mainly caused by influenza A viruses (IAVs),"/>
  <result pre="respiratory and highly infectious disease that is mainly caused by" exact="influenza" post="A viruses (IAVs), posing a serious public health problem"/>
  <result pre="health problem globally. According to the World Health Organization (WHO)," exact="influenza" post="epidemics are estimated to result in about three to"/>
  <result pre="deaths annually [1]. Further, the increase of zoonotic transmission with" exact="avian influenza" post="viruses is a growing concern [2,3]. Two classes of"/>
  <result pre="annually [1]. Further, the increase of zoonotic transmission with avian" exact="influenza" post="viruses is a growing concern [2,3]. Two classes of"/>
  <result pre="(RdRp), as well as host components (reviewed in [9,10]). The" exact="influenza" post="virus RdRp is a heterotrimer (comprised of PA, PB2,"/>
  <result pre="transcription and replication. The major role attributed to PA during" exact="influenza" post="virus infection is the endonuclease activity upon &quot;cap-snatching�? for"/>
  <result pre="and recent progress in understanding the structure and functions of" exact="influenza" post="polymerase complex has facilitated the identification of inhibitors targeting"/>
  <result pre="Japan [30,31,32]. Different screening approaches, based on cells expressing the" exact="influenza" post="virus RdRp complex, nucleoprotein (NP) and a viral mini-genomic"/>
  <result pre="mini-genomic RNA, have been recently developed for identifying inhibitors targeting" exact="influenza" post="A viral RNA transcription/replication [33,34]. However, these target-based screen"/>
  <result pre="screen to improve the accuracy and efficacy of screen for" exact="influenza" post="A virus RdRp inhibitors, and we demonstrated that this"/>
  <result pre="and 100 μg/mL of streptomycin (Invitrogen, Carlsbad, CA, USA). The" exact="influenza" post="A reporter PR8-Gluc virus and wild-type PR8 virus were"/>
  <result pre="PB2, PB1, PA, and NP) and a firefly luciferase gene-encoding" exact="influenza" post="viral minigenome using Lipofectamine 2000 (Invitrogen), according to the"/>
  <result pre="expressing PB2, PB1, PA, NP, and the firefly luciferase gene-encoding" exact="influenza" post="viral minigenome. After 4 h of incubation, the cells"/>
  <result pre="MDCK cells grown in 24-well plates were infected with the" exact="influenza" post="A PR8 virus at an MOI of 0.01. After"/>
  <result pre="constructing the mini-genomic plasmid, the open reading frame of the" exact="influenza" post="A/WSN/33 NP protein was replaced by firefly luciferase, and"/>
  <result pre="A phenotypic screening assay was developed using a replication-competent recombinant" exact="influenza" post="A virus expressing the Gaussia luciferase (Gluc), PR8-Gluc [37]."/>
  <result pre="to develop a parallel screening strategy by combining the aforementioned" exact="influenza" post="A virus RdRp-targeted assay and the PR8-Gluc virus-based assay"/>
  <result pre="and the effect of each compound on RdRp activity and" exact="influenza" post="A virus infectivity was directly compared. Three classes of"/>
  <result pre="identified: (1) hits specific to RdRp activity but not to" exact="influenza" post="replication (putative &quot;false positives�?); (2) hits shared by both"/>
  <result pre="screens were potential RdRp inhibitors; and (3) hits that inhibit" exact="influenza" post="A virus infectivity but not RdRp activity (&quot;Secondary hits�?;"/>
  <result pre="potentially target other steps rather than RNA replication/transcription in the" exact="influenza" post="virus replication cycle. Of note, cytotoxic compounds and luciferase"/>
  <result pre="JL-5001 and JL-5002, were identified to possess putative activity against" exact="influenza" post="A virus infection by targeting RdRp (Figure 4f, Table"/>
  <result pre="As a result, JL-5001 showed an inhibitory effect against the" exact="influenza" post="PR8-Gluc virus with an IC50 of 3.8 μM, while"/>
  <result pre="SI of 10.9 (Figure 5a). Moreover, the in vitro cell-based" exact="influenza" post="RdRp assay demonstrated that JL-5001 inhibited IAV RdRp activity"/>
  <result pre="5a). JL-5002 exhibited an IC50 of 1.7 μM against the" exact="influenza" post="PR8-Gluc virus and a CC50 of 10.3 μM against"/>
  <result pre="of lead compounds developed through phenotypic screening [43]. For the" exact="influenza" post="A virus, either phenotypic screens and target-based approaches are"/>
  <result pre="inhibitors is RdRp assay using cells transiently or stably expressing" exact="influenza" post="vRNP components: four viral proteins (PB2, PB1, PA, and"/>
  <result pre="a target (RdRp)-based screen and a phenotypic screen (using reporter" exact="influenza" post="A PR8-Gluc virus). The RdRp-based and PR8-Gluc virus-based screening"/>
  <result pre="screen, likely target steps other than RNA transcription/replication in the" exact="influenza" post="A virus replication cycle—steps such as virus entry, assembly,"/>
  <result pre="a target (RdRp)-based and a phenotypic (by employing a reporter" exact="influenza" post="virus) screen sequentially, to identify influenza inhibitors targeting virus"/>
  <result pre="(by employing a reporter influenza virus) screen sequentially, to identify" exact="influenza" post="inhibitors targeting virus RNA transcription/replication. A pilot screen of"/>
  <result pre="demonstrates that this strategy is a powerful approach to identify" exact="influenza" post="A virus inhibitors targeting RdRp and other steps in"/>
  <result pre="InfectionsFront. Microbiol.2016764710.3389/fmicb.2016.0045027199969 6.LackenbyA.BesselaarT.G.DanielsR.S.FryA.GregoryV.GubarevaL.V.HuangW.HurtA.C.LeangS.-K.LeeR.T.et al.Global update on the susceptibility of human" exact="influenza" post="viruses to neuraminidase inhibitors and status of novel antivirals,"/>
  <result pre="of novel antivirals, 2016–2017Antivir. Res.2018157384610.1016/j.antiviral.2018.07.00129981793 7.HataM.TsuzukiM.GotoY.KumagaiN.HaradaM.HashimotoM.TanakaS.SakaeK.KimuraT.MinagawaH.et al.High frequency of amantadine-resistant" exact="influenza" post="A (H3N2) viruses in the 2005-2006 season and rapid"/>
  <result pre="viruses in the 2005-2006 season and rapid detection of amantadine-resistant" exact="influenza" post="A (H3N2) viruses by MAMA-PCRJpn. J. Infect. Dis.20076020220417642534 8.Van"/>
  <result pre="Mechanisms of Antiviral ResistanceCurr. Med. Chem.2018255115512710.2174/092986732466617092016592628933281 11.DiasA.BouvierD.CrepinT.McCarthyA.A.HartD.J.BaudinF.CusackS.RuigrokR.W.H.The cap-snatching endonuclease of" exact="influenza" post="virus polymerase resides in the PA subunitNature200945891491810.1038/nature0774519194459 12.YuanP.BartlamM.LouZ.ChenS.ZhouJ.HeX.LvZ.GeR.LiX.DengT.et al.Crystal"/>
  <result pre="resides in the PA subunitNature200945891491810.1038/nature0774519194459 12.YuanP.BartlamM.LouZ.ChenS.ZhouJ.HeX.LvZ.GeR.LiX.DengT.et al.Crystal structure of an" exact="avian influenza" post="polymerase PA(N) reveals an endonuclease active siteNature200945890991310.1038/nature0772019194458 13.FechterP.MingayL.SharpsJ.FodorE.BrownleeG.G.ChambersA.Two Aromatic"/>
  <result pre="in the PA subunitNature200945891491810.1038/nature0774519194459 12.YuanP.BartlamM.LouZ.ChenS.ZhouJ.HeX.LvZ.GeR.LiX.DengT.et al.Crystal structure of an avian" exact="influenza" post="polymerase PA(N) reveals an endonuclease active siteNature200945890991310.1038/nature0772019194458 13.FechterP.MingayL.SharpsJ.FodorE.BrownleeG.G.ChambersA.Two Aromatic"/>
  <result pre="BindingJ. Boil. Chem.2003278203812038810.1074/jbc.M300130200 14.MaX.XieL.WartchowC.WarneR.XuY.RivkinA.TullyD.ShiaS.UeharaK.BaldwinD.M.et al.Structural basis for therapeutic inhibition of" exact="influenza" post="A polymerase PB2 subunitSci. Rep.20177938510.1038/s41598-017-09538-x28839261 15.XieL.WartchowC.ShiaS.UeharaK.SteffekM.WarneR.SuttonJ.MuiruG.T.LeonardV.H.BussiereD.E.et al.Molecular Basis of"/>
  <result pre="of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of" exact="influenza" post="PB2J. Med. Chem.2014576668667810.1021/jm500727525019388 18.FurutaY.GowenB.B.TakahashiK.ShirakiK.SmeeD.F.BarnardD.L.Favipiravir (T-705), a novel viral RNA"/>
  <result pre="of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the" exact="influenza" post="virus polymerase PA subunitAntivir. Res.201816010911710.1016/j.antiviral.2018.10.00830316915 21.YuanS.ChuH.SinghK.ZhaoH.ZhangK.KaoR.Y.T.ChowB.K.C.ZhouJ.ZhengB.-J.A novel small-molecule inhibitor"/>
  <result pre="virus polymerase PA subunitAntivir. Res.201816010911710.1016/j.antiviral.2018.10.00830316915 21.YuanS.ChuH.SinghK.ZhaoH.ZhangK.KaoR.Y.T.ChowB.K.C.ZhouJ.ZhengB.-J.A novel small-molecule inhibitor of" exact="influenza" post="A virus acts by suppressing PA endonuclease activity of"/>
  <result pre="of the viral polymeraseSci. Rep.201662288010.1038/srep2288026956222 22.YuanS.ChuH.ZhangK.YeJ.SinghK.KaoR.Y.T.ChowB.K.C.ZhouJ.ZhengB.-J.A novel small-molecule compound disrupts" exact="influenza" post="A virus PB2 cap-binding and inhibits viral replicationJ. Antimicrob."/>
  <result pre="(PA-PB1) SubunitsJ. Med. Chem.2015583830384210.1021/acs.jmedchem.5b0001225856229 24.YuanS.ChuH.ZhaoH.ZhangK.SinghK.ChowB.K.KaoR.Y.ZhouJ.ZhengB.-J.Identification of a small-molecule inhibitor of" exact="influenza" post="virus via disrupting the subunits interaction of the viral"/>
  <result pre="26.HeX.ZhouJ.BartlamM.ZhangR.MaJ.LouZ.LiX.LiJ.JoachimiakA.ZengZ.et al.Crystal structure of the polymerase PA(C)-PB1(N) complex from an" exact="avian influenza" post="H5N1 virusNature20084541123112610.1038/nature0712018615018 27.ChaseG.WunderlichK.ReutherP.SchwemmleM.Identification of influenza virus inhibitors which disrupt"/>
  <result pre="al.Crystal structure of the polymerase PA(C)-PB1(N) complex from an avian" exact="influenza" post="H5N1 virusNature20084541123112610.1038/nature0712018615018 27.ChaseG.WunderlichK.ReutherP.SchwemmleM.Identification of influenza virus inhibitors which disrupt"/>
  <result pre="PA(C)-PB1(N) complex from an avian influenza H5N1 virusNature20084541123112610.1038/nature0712018615018 27.ChaseG.WunderlichK.ReutherP.SchwemmleM.Identification of" exact="influenza" post="virus inhibitors which disrupt of viral polymerase protein–protein interactionsMethods20115518819110.1016/j.ymeth.2011.08.00721867756"/>
  <result pre="for Next-Generation Anti-influenza TherapeuticsJ. Med. Chem.2016597699771810.1021/acs.jmedchem.5b0147427046062 29.MuratoreG.GoracciL.MercorelliB.FoegleinA.DigardP.CrucianiG.PaluG.LoregianA.Small molecule inhibitors of" exact="influenza" post="A and B viruses that act by disrupting subunit"/>
  <result pre="Transcription and ReplicationPLoS ONE201510e013355810.1371/journal.pone.013355826196128 34.OzawaM.ShimojimaM.GotoH.WatanabeS.HattaY.KisoM.FurutaY.HorimotoT.PetersN.R.HoffmannF.M.et al.A cell-based screening system for" exact="influenza" post="A viral RNA transcription/replication inhibitorsSci. Rep.20133110610.1038/srep0110623346363 35.ZhaoX.WangL.CuiQ.LiP.WangY.ZhangY.YangY.RongL.DuR.A Mechanism Underlying"/>
  <result pre="AntibodiesJ. Virol.2013878272828110.1128/JVI.00969-1323698304 38.GaoQ.WangZ.LiuZ.LiX.ZhangY.ZhangZ.CenS.A cell-based high-throughput approach to identify inhibitors of" exact="influenza" post="A virusActa Pharm. Sin. B2014430130610.1016/j.apsb.2014.06.00526579399 39.ChengH.KoningK.O’HearnA.WangM.Rumschlag-BoomsE.VarhegyiE.RongL.A parallel genome-wide RNAi"/>
  <result pre="host proteins important for entry of Marburg virus and H5N1" exact="influenza" post="virusVirol. J.20151266510.1186/s12985-015-0420-3 40.CuiQ.ChengH.XiongR.ZhangG.DuR.AnantpadmaM.DaveyR.A.RongL.Identification of Diaryl-Quinoline Compounds as Entry Inhibitors"/>
  <result pre="modes of actionIUBMB Life20187092210.1002/iub.169729210173 44.SuC.Y.ChengT.J.LinM.I.WangS.Y.HuangW.I.Lin-ChuS.Y.ChenY.H.WuC.Y.LaiM.M.ChengW.C.et al.High-throughput identification of compounds targeting" exact="influenza" post="RNA-dependent RNA polymerase activityProc. Natl. Acad. Sci. USA2010107191511915610.1073/pnas.101359210720974907 45.WeisshaarM.CoxR.MorehouseZ.KyasaS.K.YanD.OberackerP.MaoS.GoldenJ.E.LowenA.C.NatchusM.G.et"/>
  <result pre="Dual Myxovirus High-Throughput ScreeningJ. Virol.2016907368738710.1128/JVI.00898-1627252534 Figure 1 Optimization of cell-based" exact="influenza" post="RNA-dependent RNA polymerase (RdRp) assay in a high-throughput screen"/>
  <result pre="Establishment of a high-throughput screen system using the replication-competent recombinant" exact="influenza" post="virus carrying Gaussia luciferase, PR8-Gluc. (a) Signal range of"/>
  <result pre="Madin-Darby canine kidney (MDCK) cells were infected with the reporter" exact="influenza" post="virus PR8-Gluc virus at multiplicities of infection (MOIs) of"/>
 </snippets>
</snippetsTree>
